Advertisement

Surgery Today

, Volume 47, Issue 4, pp 425–431 | Cite as

Mesenchymal stem cells attenuate ischemia–reperfusion injury after prolonged cold ischemia in a mouse model of lung transplantation: a preliminary study

  • Tatsuaki Watanabe
  • Yasushi Hoshikawa
  • Naoya Ishibashi
  • Hirotoshi Suzuki
  • Hirotsugu Notsuda
  • Yui Watanabe
  • Masafumi Noda
  • Masahiko Kanehira
  • Shinya Ohkouchi
  • Takashi Kondo
  • Yoshinori Okada
Original Article

Abstract

Purpose

Mesenchymal stem cells (MSCs) suppress inflammation and immune responses. We conducted this study to find out if MSCs attenuate ischemia–reperfusion injury in a mouse model of lung transplantation.

Methods

C57BL/6J mouse lungs perfused with low-potassium dextran glucose solution were preserved at 4 °C for 18 h. Human MSCs were slowly injected into the left pulmonary artery of the lung grafts, and orthotopic left lung transplantation was then performed. The lung isografts were reperfused for 6 h, and bronchoalveolar lavage fluid (BALF) from the left lung graft was collected. We measured the protein concentration, cell count, and proinflammatory cytokine concentrations in the BALF.

Results

The protein concentration and cell count in the BALF were significantly lower in the MSC-administered grafts than in the PBS-administered controls. Concentrations of proinflammatory cytokines, including IL-1β, IL-17A, and TNF-α, in BALF tended to be lower in the MSC-administered grafts than in the controls, but the difference was not significant.

Conclusion

The pre-transplant administration of MSCs via the pulmonary artery of the lung graft attenuated ischemia–reperfusion injury after prolonged cold ischemia in this mouse model of lung transplantation.

Keywords

Mesenchymal stem cells Ischemia–reperfusion injury Lung transplantation 

Notes

Acknowledgments

We thank Dr. Naohisa Waki of the Department of Cancer and Thoracic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan, for his help with the mouse model of lung transplantation. This work was supported by JSPS KAKENHI Grant Number 26870042.

Compliance with ethical standards

Conflict of interest

Tatsuaki Watanabe and his co-authors have no conflicts of interest.

References

  1. 1.
    Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012;31:1073–86.CrossRefPubMedGoogle Scholar
  2. 2.
    Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, et al. Ischemia–reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg. 2002;73:1041–7 (discussion 7–8).CrossRefPubMedGoogle Scholar
  3. 3.
    den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL. Lung ischemia–reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010;299:H1283–99.CrossRefGoogle Scholar
  4. 4.
    Kreisel D, Goldstein DR. Innate immunity and organ transplantation: focus on lung transplantation. Transpl Int. 2013;26:2–10.CrossRefPubMedGoogle Scholar
  5. 5.
    Oishi H, Okada Y, Saiki Y, Sado T, Noda M, Hoshikawa Y, et al. Successful bilateral lung transplantation after 16 h of lung preservation with EP-TU solution: report of a case. Surg Today. 2015;45:630–3.CrossRefPubMedGoogle Scholar
  6. 6.
    Okada Y, Matsumura Y, Date H, Bando T, Oto T, Sado T, et al. Clinical application of an extracellular phosphate-buffered solution (EP-TU) for lung preservation: preliminary results of a Japanese series. Surg Today. 2012;42:152–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Utsunomiya T, Shimada M, Imura S, Morine Y, Ikemoto T, Mori H, et al. Human adipose-derived stem cells: potential clinical applications in surgery. Surg Today. 2011;41:18–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Frank MH, Sayegh MH. Immunomodulatory functions of mesenchymal stem cells. Lancet. 2004;363:1411–2.CrossRefPubMedGoogle Scholar
  9. 9.
    Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499–506.CrossRefPubMedGoogle Scholar
  10. 10.
    Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther. 2009;17:939–46.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18:759–65.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 2007;4:e269.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    La Manna G, Bianchi F, Cappuccilli M, Cenacchi G, Tarantino L, Pasquinelli G, et al. Mesenchymal stem cells in renal function recovery after acute kidney injury: use of a differentiating agent in a rat model. Cell Transplant. 2011;20:1193–208.CrossRefPubMedGoogle Scholar
  14. 14.
    Kim YS, Ahn Y, Kwon JS, Cho YK, Jeong MH, Cho JG, et al. Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury. Cells Tissues Organs. 2012;195:428–42.CrossRefPubMedGoogle Scholar
  15. 15.
    Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, Negishi K, et al. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One. 2011;6:e19195.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54:1418–37.CrossRefPubMedGoogle Scholar
  17. 17.
    Oishi H, Okada Y, Kikuchi T, Hoshikawa Y, Sado T, Noda M, et al. Transbronchial human interleukin-10 gene transfer reduces acute inflammation associated with allograft rejection and intragraft interleukin-2 and tumor necrosis factor-alpha gene expression in a rat model of lung transplantation. J Heart Lung Transplant. 2010;29:360–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Kanehira M, Kikuchi T, Ohkouchi S, Shibahara T, Tode N, Santoso A, et al. Targeting lysophosphatidic acid signaling retards culture-associated senescence of human marrow stromal cells. PLoS One. 2012;7:e32185.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Okazaki M, Krupnick AS, Kornfeld CG, Lai JM, Ritter JH, Richardson SB, et al. A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant. 2007;7:1672–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Okada Y, Marchevsky AM, Zuo XJ, Pass JA, Kass RM, Matloff JM, et al. Accumulation of platelets in rat syngeneic lung transplants: a potential factor responsible for preservation-reperfusion injury. Transplantation. 1997;64:801–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Lin X, Li W, Lai J, Okazaki M, Sugimoto S, Yamamoto S, et al. Five-year update on the mouse model of orthotopic lung transplantation: scientific uses, tricks of the trade, and tips for success. J Thorac Dis. 2012;4:247–58.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Parker JC, Townsley MI. Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol. 2004;286:L231–46.CrossRefPubMedGoogle Scholar
  24. 24.
    Eltzschig HK, Eckle T. Ischemia and reperfusion—from mechanism to translation. Nat Med. 2011;17:1391–401.CrossRefPubMedGoogle Scholar
  25. 25.
    Shimada S, Fukai M, Wakayama K, Ishikawa T, Kobayashi N, Kimura T, et al. Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver. Surg Today. 2015;45:892–903.CrossRefPubMedGoogle Scholar
  26. 26.
    Souidi N, Stolk M, Seifert M. Ischemia–reperfusion injury: beneficial effects of mesenchymal stromal cells. Curr Opin Organ Transplant. 2013;18:34–43.CrossRefPubMedGoogle Scholar
  27. 27.
    Ariel A, Serhan CN. New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front Immunol. 2012;3:4.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood. 2011;118:330–8.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A, et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells. 2014;32:116–25.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Curley GF, Ansari B, Hayes M, Devaney J, Masterson C, Ryan A, et al. Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury. Anesthesiology. 2013;118:924–32.CrossRefPubMedGoogle Scholar
  31. 31.
    Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Rossignol J, Boyer C, Thinard R, Remy S, Dugast AS, Dubayle D, et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med. 2009;13:2547–58.CrossRefPubMedGoogle Scholar
  33. 33.
    Hao Q, Zhu YG, Monsel A, Gennai S, Lee T, Xu F, et al. Study of bone marrow and embryonic stem cell-derived human mesenchymal stem cells for treatment of escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells Transl Med. 2015;4:832–40.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Kim ES, Chang YS, Choi SJ, Kim JK, Yoo HS, Ahn SY, et al. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir Res. 2011;12:108.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Van Raemdonck D, Neyrinck A, Rega F, Devos T, Pirenne J. Machine perfusion in organ transplantation: a tool for ex vivo graft conditioning with mesenchymal stem cells? Curr Opin Organ Transplant. 2013;18:24–33.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan 2016

Authors and Affiliations

  • Tatsuaki Watanabe
    • 1
  • Yasushi Hoshikawa
    • 1
  • Naoya Ishibashi
    • 1
  • Hirotoshi Suzuki
    • 1
  • Hirotsugu Notsuda
    • 1
  • Yui Watanabe
    • 1
  • Masafumi Noda
    • 1
  • Masahiko Kanehira
    • 1
  • Shinya Ohkouchi
    • 2
  • Takashi Kondo
    • 1
  • Yoshinori Okada
    • 1
  1. 1.Department of Thoracic Surgery, Institute of Development, Aging and CancerTohoku UniversitySendaiJapan
  2. 2.Department of Respiratory MedicineTohoku University Graduate School of MedicineSendaiJapan

Personalised recommendations